Labeler
Eli Lilly and Company NDC Codes
Eli Lilly and Company lists 148 finished drug products in the FDA NDC Directory under NDC labeler code 0002.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Zepbound, Mounjaro, Omvoh, Foundayo, Mounjaro KwikPen, Zepbound KwikPen, Retevmo, Olumiant, Emgality, Ebglyss, Taltz, Jaypirca, Trulicity, Lyumjev, LYUMJEV KwikPen
- Active ingredients
- Tirzepatide, Insulin lispro, Orforglipron calcium, Selpercatinib, Mirikizumab, Baricitinib, Galcanezumab, Lebrikizumab, Ixekizumab, Pirtobrutinib, Dulaglutide, Lasmiditan
- NDC labeler codes
- 0002
- Strengths (from the 100 most recently listed products)
- Insulin lispro 100 [iU]/mL; Tirzepatide 25 mg/mL; Tirzepatide 12.5 mg/mL; Tirzepatide 20.8 mg/mL; Tirzepatide 8.33 mg/mL; Tirzepatide 16.7 mg/mL; Tirzepatide 4.17 mg/mL; Mirikizumab 100 mg/mL; Tirzepatide 2.5 mg/.5mL; Tirzepatide 12.5 mg/.5mL; Tirzepatide 7.5 mg/.5mL; Tirzepatide 10 mg/.5mL; Tirzepatide 5 mg/.5mL; Tirzepatide 15 mg/.5mL; Lebrikizumab 250 mg/2mL; Selpercatinib 40 mg/1; Selpercatinib 80 mg/1; Baricitinib 4 mg/1; Galcanezumab 120 mg/mL; Orforglipron calcium 2.5 mg/1
- Dosage forms
- Injection, Solution, Tablet, Film coated, Tablet, Coated, Tablet, Kit, Capsule, Injection, Suspension
- Routes
- Subcutaneous, Oral, Intravenous
- Drug classes (FDA established)
- GLP-1 Receptor Agonist, Glucose-dependent Insulinotropic Polypeptide Receptor Agonist, Insulin Analog, Kinase Inhibitor, Interleukin-23 Antagonist, Janus Kinase Inhibitor, Interleukin-13 Antagonist, Interleukin-17A Antagonist, Estrogen Receptor Antagonist, Parathyroid Hormone Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 126 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Foundayoorforglipron | Orforglipron calcium 2.5 mg/1 | Tablet, Film coatedOral | 0002-4503 | 00002-4503-31 | — |
| Foundayoorforglipron | Orforglipron calcium .8 mg/1 | Tablet, Film coatedOral | 0002-4178 | 00002-4178-3100002-4178-62 | — |
| Foundayoorforglipron | Orforglipron calcium 5.5 mg/1 | Tablet, Film coatedOral | 0002-4794 | 00002-4794-31 | — |
| Foundayoorforglipron | Orforglipron calcium 14.5 mg/1 | Tablet, Film coatedOral | 0002-4839 | 00002-4839-31 | — |
| Foundayoorforglipron | Orforglipron calcium 9 mg/1 | Tablet, Film coatedOral | 0002-4803 | 00002-4803-31 | — |
| Foundayoorforglipron | Orforglipron calcium 17.2 mg/1 | Tablet, Film coatedOral | 0002-4953 | 00002-4953-31 | — |
| Mounjaro KwikPentirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | 0002-3411 | 00002-3411-11 | — |
| Mounjaro KwikPentirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | 0002-3444 | 00002-3444-11 | — |
| Zepbound KwikPentirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | 0002-3511 | 00002-3511-11 | — |
| Zepbound KwikPentirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | 0002-3544 | 00002-3544-11 | — |
| Mounjaro KwikPentirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | 0002-3422 | 00002-3422-11 | — |
| Mounjaro KwikPentirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | 0002-3455 | 00002-3455-11 | — |
| Zepbound KwikPentirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | 0002-3522 | 00002-3522-11 | — |
| Zepbound KwikPentirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | 0002-3555 | 00002-3555-11 | — |
| Mounjaro KwikPentirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | 0002-3433 | 00002-3433-11 | — |
| Mounjaro KwikPentirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | 0002-3466 | 00002-3466-11 | — |
| Zepbound KwikPentirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | 0002-3533 | 00002-3533-11 | — |
| Zepbound KwikPentirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | 0002-3566 | 00002-3566-1100002-3566-99 | — |
| Zepboundtirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | 0002-6103 | 00002-6103-11 | — |
| Zepboundtirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | 0002-6612 | 00002-6612-11 | — |
| Mounjarotirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | 0002-4210 | 00002-4210-11 | — |
| Zepboundtirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | 0002-6052 | 00002-6052-11 | — |
| Zepboundtirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | 0002-6304 | 00002-6304-11 | — |
| Mounjarotirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | 0002-4052 | 00002-4052-11 | — |
| Mounjarotirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | 0002-4304 | 00002-4304-11 | — |
| Mounjarotirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | 0002-4523 | 00002-4523-11 | — |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | 0002-6210 | 00002-6210-11 | — |
| Zepboundtirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | 0002-6523 | 00002-6523-11 | — |
| Mounjarotirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | 0002-4103 | 00002-4103-11 | — |
| Mounjarotirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | 0002-4612 | 00002-4612-11 | — |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | 0002-1442 | 00002-1442-11 | — |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | 0002-3116 | 00002-3116-1100002-3116-61 | — |
| Inluriyoimlunestrant | Imlunestrant 200 mg/1 | Tablet, Film coatedOral | 0002-1717 | 00002-1717-2800002-1717-5600002-1717-61 | — |
| Forteoteriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | 0002-9678 | 00002-9678-01 | — |
| Omvohmirikizumab-mrkz | — | KitSubcutaneous, Subcutaneous | 0002-7717 | 00002-7717-1100002-7717-61 | — |
| Omvohmirikizumab-mrkz | — | KitSubcutaneous, Subcutaneous | 0002-7722 | 00002-7722-11 | — |
| Ebglysslebrikizumab-lbkz | Lebrikizumab 250 mg/2mL | Injection, SolutionSubcutaneous | 0002-7772 | 00002-7772-1100002-7772-62 | — |
| Ebglysslebrikizumab-lbkz | Lebrikizumab 250 mg/2mL | Injection, SolutionSubcutaneous | 0002-7797 | 00002-7797-1100002-7797-61 | — |
| Kisunladonanemab-azbt | Donanemab 17.5 mg/mL | Injection, SolutionIntravenous | 0002-9401 | 00002-9401-01 | — |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | 0002-8870 | 00002-8870-27 | — |
| Retevmoselpercatinib | Selpercatinib 160 mg/1 | Tablet, CoatedOral | 0002-5562 | 00002-5562-60 | — |
| Retevmoselpercatinib | Selpercatinib 120 mg/1 | Tablet, CoatedOral | 0002-6120 | 00002-6120-60 | — |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | Tablet, CoatedOral | 0002-5340 | 00002-5340-60 | — |
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | Tablet, CoatedOral | 0002-6082 | 00002-6082-60 | — |
| Zepboundtirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-0152 | 00002-0152-0100002-0152-0400002-0152-61 | — |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1423 | 00002-1423-0100002-1423-04 | — |
| Zepboundtirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1214 | 00002-1214-0100002-1214-04 | — |
| Zepboundtirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | 0002-1340 | 00002-1340-0100002-1340-04 | — |
| Zepboundtirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | 0002-0243 | 00002-0243-0100002-0243-04 | — |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | 0002-2002 | 00002-2002-0100002-2002-04 | — |
Eli Lilly and Company: common questions
- What is Eli Lilly and Company's NDC labeler code?
- 0002. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Eli Lilly and Company?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.